PLYMOUTH MEETING, Pa., Nov. 23, 2015 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today reported that Dr. J. Joseph Kim, President and CEO, will participate in the Piper Jaffray 27th Annual Healthcare Conference on Wednesday, December 2nd at 3:30PM ET.
A live and archived version of Dr. Kim’s fireside chat will be made available through the “Webcast” tab on Inovio’s home page at www.inovio.com as well as at the following URL: http://bit.ly/1MzG9xi.
About Inovio Pharmaceuticals, Inc.
Inovio is taking immunotherapy to the next level in the fight against cancer and infectious diseases. We are the only immunotherapy company that is generating T cells in vivo in high quantity that are fully functional and whose killing capacity correlates with relevant clinical outcomes with a favorable safety profile. With an expanding portfolio of immune therapies, the company is advancing a growing preclinical and clinical stage product pipeline. Partners and collaborators include MedImmune, Roche, University of Pennsylvania, DARPA, GeneOne Life Science, Drexel University, NIH, HIV Vaccines Trial Network, National Cancer Institute, U.S. Military HIV Research Program, and University of Manitoba. For more information, visit www.inovio.com.
